Novo Nordisk's Wegovy, Apple Air, Palantir: Top Stories

Wealth big Madison Mills explores respective trending stocks this morning:

Novo Nordisk (NVO) is offering its GLP-1 weight-loss cause Wegovy at a important discount for uninsured patients.

Apple (AAPL) unveils its caller MacBook Air featuring an m4 chip, iPad Air, and its Mac Studio desktop, the second priced astatine $3,999.

Palantir Technologies (PLTR) receives an upgrade from William Blair analysts to Market Perform from Underperform.

To ticker much adept insights and investigation connected the latest marketplace action, cheque retired much Wealth here.

This station was written by Luke Carberry Mogan.

Related Videos